Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression
暂无分享,去创建一个
[1] S. Charalambous,et al. A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa , 2011, BMC health services research.
[2] S. Lawn,et al. Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[3] S. Lawn,et al. Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa , 2011, Journal of acquired immune deficiency syndromes.
[4] U. Unicef,et al. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .
[5] L. Myer,et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007 , 2010, AIDS.
[6] Roger Paredes,et al. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. , 2010, The Journal of infectious diseases.
[7] B. Rau,et al. Decentralizing antiretroviral treatment services at primary health care facilities: a guide to expanding access and care in resource-limited, generalized HIV epidemic settings , 2010 .
[8] L. Myer,et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa , 2008, AIDS.
[9] Karen Cohen,et al. Antiretroviral therapy and early mortality in South Africa. , 2008, Bulletin of the World Health Organization.
[10] L. Myer,et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. , 2008, Bulletin of the World Health Organization.
[11] E. Schouten,et al. What Happens to Patients on Antiretroviral Therapy Who Transfer Out to Another Facility? , 2008, PloS one.
[12] Sydney Rosen,et al. Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.
[13] L. Myer,et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control , 2006, AIDS.
[14] J. Sterne,et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.
[15] L. Myer,et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design , 2005, AIDS.
[16] I. Thior,et al. Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana , 2005, Journal of acquired immune deficiency syndromes.
[17] C. Sabin,et al. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre , 2001, AIDS.
[18] M. Moroni,et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients , 2000, AIDS.